Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Pregabalin
Drug ID BADD_D01835
Description Pregabalin is structurally similar to gamma-aminobutyric acid (GABA) - an inhibitory neurotransmitter.[A173995] It may be used to manage neuropathic pain, postherpetic neuralgia, and fibromyalgia among other conditions.[A187190] Although as per the FDA Label the mechanism of action has not been definitively defined, there is evidence that pregabalin exerts its effects by binding to the α2δ subunit of voltage-dependent calcium channels.[A187190][L7066] Pregabalin is marketed by Pfizer under the trade name Lyrica and Lyrica Cr (extended release).[L1006][L7066] It may have dependence liability if misused but the risk appears to be highest in patients with current or past substance use disorders.[A31161]
Indications and Usage Pregabalin is used for the management of neuropathic pain associated with diabetic peripheral neuropathy or spinal cord injury, and postherpetic neuralgia. It is not approved for the management of fibromyalgia or as adjuntive therapy for adult partial onset seizures.[FDA label]
Marketing Status Prescription
ATC Code N03AX16
DrugBank ID DB00230
KEGG ID D02716
MeSH ID D000069583
PubChem ID 5486971
TTD Drug ID D00WUF
NDC Product Code 69238-1315; 72189-032; 71335-1476; 0228-2860; 59762-1354; 63539-014; 59762-1364; 72189-028; 55700-956; 59762-1348; 64980-413; 71335-1791; 71335-2012; 71335-1744; 76420-124; 55700-827; 0071-1017; 72189-269; 43598-297; 72658-0811; 71205-556; 53869-1473; 80425-0129; 69539-012; 80425-0124; 55700-804; 71335-1745; 72189-035; 72189-023; 76420-099; 69097-957; 69367-326; 60219-1317; 76282-574; 27808-237; 55700-805; 80425-0123; 68788-7524; 76282-572; 76420-097; 76420-100; 59762-1576; 0071-1012; 42419-019; 76420-121; 42385-308; 76420-123; 71205-298; 69097-955; 63629-3369; 64980-414; 71335-1790; 72658-0812; 69097-956; 71205-876; 69097-961; 66174-0031; 69367-329; 72189-251; 80425-0185; 60219-1316; 72189-033; 60219-1314; 66651-915; 0228-2858; 60219-1310; 31722-614; 43598-296; 69238-1317; 72658-0849; 72658-0808; 55154-2431; 76420-118; 31722-615; 72658-0813; 0071-1018; 27808-235; 69539-015; 69367-330; 71610-356; 47781-381; 72606-008; 60687-506; 51407-510; 0228-2861; 0904-7004; 71335-1300; 43353-263; 47335-691; 63304-048; 71335-1822; 69097-954; 0071-1026; 60760-205; 62350-0072; 76420-098; 53869-1016; 55154-2430; 70518-2763; 72189-021; 71335-1505; 60219-1312; 63629-8198; 71335-2015; 71610-316; 53869-1018; 0071-1019; 0904-7005; 71335-2000; 0071-1016; 72888-051; 70518-2571; 71610-351; 0904-7002; 62332-121; 71610-358; 45865-126; 69367-331; 55700-904; 50436-0325; 0904-7003; 71610-331; 63539-024; 68788-7523; 76282-569; 70518-2568; 31722-616; 71610-334; 55700-817; 15894-0016; 71205-875; 71335-1459; 72189-020; 60687-495; 60687-517; 76282-568; 72888-049; 66039-926; 80425-0025; 47335-688; 63629-8196; 69238-1312; 72205-013; 68788-7656; 71205-304; 46708-125; 72658-0814; 69539-128; 70518-2948; 71205-338; 60687-484; 71205-871; 64980-417; 80425-0029; 53869-1014; 71610-365; 80425-0147; 53869-1010; 43353-414; 71610-333; 71610-328; 71335-1792; 63629-4181; 70518-2745; 50228-350; 43598-291; 72643-010; 71335-1758; 60219-1315; 50370-0013; 65015-857; 72189-034; 80425-0026; 66577-034; 80425-0152; 67877-466; 47335-687; 50090-5071; 0228-2862; 67877-465; 76282-573; 55700-964; 63629-8199; 43598-295; 43353-264; 47781-379; 70518-2980; 31722-611; 63629-8208; 60760-486; 64980-412; 16812-003; 70518-2525; 69539-018; 59762-1360; 59285-002; 0071-1027; 0228-2859; 80425-0166; 69238-1314; 60219-1311; 76282-570; 71205-869; 72640-002; 69539-129; 27808-236; 47781-380; 67877-467; 72606-007; 80425-0028; 76420-117; 70518-2762; 53869-1013; 72189-164; 72658-0809; 60760-509; 65862-790; 47335-690; 61919-503; 63629-8197; 71205-323; 80425-0116; 72189-019; 0071-1020; 50090-5038; 50090-5177; 27808-239; 55700-891; 70518-3345; 62332-123; 60219-1313; 70518-2689; 69367-325; 70518-2569; 67877-463; 69238-1311; 71610-317; 69367-328; 50228-355; 51407-511; 68788-7521; 70518-2364; 17337-0421; 70518-2290; 0071-1014; 69539-011; 50228-357; 69097-962; 69097-959; 0071-1013; 71610-335; 43598-294; 55289-257; 71610-319; 43353-675; 76282-575; 46708-120; 71205-396; 55111-882; 0071-1015; 43598-293; 47335-693; 72189-328; 63629-8195; 72189-045; 62332-119; 60687-473; 69238-1310; 59762-1342; 71610-071; 67877-468; 53869-1011; 72205-018; 62332-124; 0228-2857; 71610-329; 45865-108; 71610-330; 71610-361; 71205-608; 72205-017; 50228-354; 71205-873; 67877-462; 71610-357; 31722-612; 43598-298; 72205-012; 63629-8248; 62332-125; 68724-1235; 50228-356; 55289-569; 69238-1316; 60760-507; 59762-1351; 69097-958; 0228-2863; 69238-1313; 50228-351
Synonyms Pregabalin | (S)-3-(aminomethyl)-5-methylhexanoic acid | 3-isobutyl GABA | 3 isobutyl GABA | GABA, 3-isobutyl | 3-(aminomethyl)-5-methylhexanoic acid | (R-)-3-isobutyl GABA | (S+)-3-isobutyl GABA | Lyrica | CI 1008 | 1008, CI | CI-1008 | CI1008
Chemical Information
Molecular Formula C8H17NO2
CAS Registry Number 148553-50-8
SMILES CC(C)CC(CC(=O)O)CN
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Atrioventricular block first degree02.03.01.004--
Atrioventricular block second degree02.03.01.0050.000590%
Atrophy08.03.04.0010.000472%Not Available
Attention deficit/hyperactivity disorder19.21.04.001--Not Available
Autoimmune hepatitis09.01.07.019; 10.04.09.001--Not Available
Autonomic nervous system imbalance24.06.01.005; 17.05.01.011; 08.01.01.0100.000472%Not Available
Azotaemia20.01.01.001--Not Available
Back disorder15.03.01.0140.005072%Not Available
Back pain15.03.04.0050.016396%
Balanoposthitis21.09.03.001--Not Available
Barrett's oesophagus07.11.03.0020.000236%Not Available
Benign neoplasm of skin23.10.01.006; 16.26.01.006--Not Available
Benign prostatic hyperplasia21.04.02.001--Not Available
Biliary colic09.02.01.001--Not Available
Bilirubin conjugated increased13.03.01.0070.000236%Not Available
Bipolar I disorder19.16.01.0020.000590%Not Available
Bladder cancer20.03.04.001; 16.08.01.001--Not Available
Bladder neoplasm20.03.04.002; 16.08.03.002--Not Available
Bladder pain20.02.02.0010.000236%Not Available
Blepharitis06.04.04.001; 23.03.04.012--Not Available
Blepharospasm06.05.01.001; 17.17.02.0010.000354%Not Available
Blindness06.02.02.001; 17.17.01.0030.005780%Not Available
Blindness transient17.17.01.004; 06.02.02.0020.000826%Not Available
Blindness unilateral17.17.01.016; 06.02.02.0090.000590%Not Available
Blister23.03.01.001; 12.01.06.0020.005072%Not Available
Blood albumin decreased13.09.01.0010.000472%Not Available
Blood bilirubin increased13.03.01.008--
Blood calcium decreased13.11.01.002--Not Available
Blood cholesterol increased13.12.01.002--
Blood creatine phosphokinase increased13.04.01.0010.003539%
The 4th Page    First    Pre   4 5 6 7 8    Next   Last    Total 55 Pages